NMC Health Plc Notice of Full Year Results (6428Q)
21 February 2019 - 12:43AM
UK Regulatory
TIDMNMC
RNS Number : 6428Q
NMC Health Plc
20 February 2019
20 February 2019
NMC Health plc
(the "Company" or "NMC")
Notice of Full Year Results on 7 March 2019
NMC Health plc (LSE: NMC), the leading private healthcare
operator in the Gulf Cooperation Council (GCC) with international
services across 18 countries, will report its full year financial
results (for the 12 months to 31 December 2018) on Thursday, 7
March 2019.
The results are expected to be published on the Regulatory News
Service of the London Stock Exchange at 7am GMT on 7 March 2019 and
shortly thereafter on the Company's website at
https://nmc.ae/investor-relations.
Contacts
NMC
Prasanth Manghat, Chief Executive
Officer
Prashanth Shenoy, Chief Financial +971 (0)50 522 5648
Officer +971 (0)56 329 0545
Asjad Yahya, Investor Relations +971 (0)56 219 0975
Media
FTI Consulting, London
Brett Pollard / Victoria Foster Mitchell +44 (0)20 3727 1000
FTI Consulting, Gulf
Shane Dolan +971 (0)4 437 2100
About NMC Health
NMC the leading private healthcare operator in the GCC with an
international network of hospitals across 18 countries. NMC also
ranks as one of the top three in-vitro fertilisation ("IVF")
operators globally. The Group is also a leading provider of
long-term medical care in the UAE through its subsidiary ProVita.
Pursing an aggressive international expansion program from 2016,
the company now has over 34% of its licensed bed capacity in the
Kingdom of Saudi Arabia (KSA), where the company has introduced
long-term and multi-specialty care services. Moreover, the recent
formation of a joint venture with GOSI/Hassana Investment Company
is set to substantially boost the Group's bed capacity in KSA, with
the JV expected to be the second largest healthcare operator in the
Kingdom in terms of number of beds. NMC received over 5.7m patients
in 2017. The Group is also a leading UAE supplier of products and
consumables across several key market segments, with the major
contribution coming from healthcare related products. The Group
reported revenues of US$1.6 billion for the year ended 31 December
2017.
In April 2012 NMC was listed on the Premium Segment of the
London Stock Exchange. NMC is a constituent of the FTSE 100
Index.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORURSORKAAUUAR
(END) Dow Jones Newswires
February 20, 2019 08:43 ET (13:43 GMT)
Nmc Health (LSE:NMC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nmc Health (LSE:NMC)
Historical Stock Chart
From Apr 2023 to Apr 2024
Real-Time news about Nmc Health Plc (London Stock Exchange): 0 recent articles
More Nmc Health News Articles